Dengue virus antigen IVD, reagent - UK MHRA Medical Device Registration

Dengue virus antigen IVD, reagent is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 194352. The device is manufactured by Bifour Biotech Inc. from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is SUNGO Certification Company Limited.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

MHRA Registered

In Vitro Diagnostic Device

🇬🇧

Dengue virus antigen IVD, reagent

MHRA Device ID: 194352•Ref: 194352

Device Type

In Vitro Diagnostic Device

Devices

Dengue virus antigen IVD, reagent

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

May 31, 2024

Manufacturer Information

Name

Bifour Biotech Inc.

Address

4677 Old Ironsides Drive, Suite 300,Santa Clara

California, United States

Created Date

May 24, 2024

Authorized Representative

Name

SUNGO Certification Company Limited

Relationship Type

UK Responsible Person

Address

3rd Floor, 70 Gracechurch Street

London, England, United Kingdom

Postcode: EC3V 0HR

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Other Products from Bifour Biotech Inc. (10)

Other Products from Same Authorized Representative (10)

Dengue virus antigen IVD, reagent - UK MHRA Medical Device Registration

Device Type

Devices

Type

Date Registered

Last Updated

Name

Address

Created Date

Name

Relationship Type

Address

DJ Fang

Prothrombin time (PT) IVD, reagent

Dengue virus immunoglobulin G (IgG)/IgM antibody IVD, kit, rapid ICT, clinical

Multiple gastrointestinal virus antigen IVD, kit, rapid ICT, clinical

Total cortisol IVD, reagent

B-type natriuretic protein/N-terminal pro b-type natriuretic peptide IVD, kit, fluorescent immunoassay

Creatine kinase myocardial isoenzyme (CKMB) IVD, kit, fluorescent immunoassay

Clostridium difficile antigen IVD, antibody

Influenza A/B virus antigen IVD, kit, rapid ICT, clinical

Mycobacterium tuberculosis complex species antigen IVD, kit, rapid ICT, clinical

Fentanyl IVD, kit, rapid ICT, clinical

Adenovirus antigen IVD, kit, fluorescent immunoassay

Anti-Mullerian hormone (AMH) IVD, reagent

B-type natriuretic protein/N-terminal pro b-type natriuretic peptide IVD, kit, fluorescent immunoassay

Beta-2-microglobulin IVD, reagent

Cancer antigen 125 (CA125) IVD, kit, fluorescent immunoassay

Chlamydia trachomatis antigen IVD, kit, rapid ICT, clinical

Cholylglycine bile acid IVD, reagent

Cystatin C IVD, reagent

Evacuated blood collection tube IVD, anticoagulant

General specimen collection kit IVD, clinical

Interleukin-6 (IL-6) IVD, control

Procalcitonin (PCT) IVD, control

Procalcitonin (PCT) IVD, kit, chemiluminescent immunoassay

Progesterone IVD, control

Total human chorionic gonadotropin IVD, control

Total human chorionic gonadotropin IVD, kit, chemiluminescent immunoassay

Troponin T IVD, control

Blood gas analyser IVD, point-of-care

Multiple Orthopoxvirus nucleic acid IVD, kit, nucleic acid technique (NAT)

Creatine?kinase?myocardial?isoenzyme (CKMB) IVD, kit, chemiluminescent immunoassay